TABLE OF CONTENTS
Volume 8, Issue 1 (March 2005)
Editorial
Report from Durham
J Moul
Prostate Cancer Prostatic Dis 8: 1; doi:10.1038/sj.pcan.4500795
Research Highlights
Prostate News
Prostate Cancer Prostatic Dis 8: 2-6; doi:10.1038/sj.pcan.4500793
Reviews
Apoptotic regulators in prostatic intraepithelial neoplasia (PIN): value in prostate cancer detection and prevention
L Zeng and N Kyprianou
Prostate Cancer Prostatic Dis 8: 7-13; advance online publication, October 12, 2004; doi:10.1038/sj.pcan.4500757
Proteome analysis of prostate cancer
H Kuruma, S Egawa, M Oh-Ishi, Y Kodera and T Maeda
Prostate Cancer Prostatic Dis 8: 14-21; advance online publication, October 12, 2004; doi:10.1038/sj.pcan.4500764
The impact of age and comorbidity on survival outcomes and treatment patterns in prostate cancer
W H Hall, A B Jani, J K Ryu, S Narayan and S Vijayakumar
Prostate Cancer Prostatic Dis 8: 22-30; advance online publication, February 8, 2005; doi:10.1038/sj.pcan.4500772
Salvage cryosurgery for locally recurrent prostate cancer following radiotherapy
S Ahmed, B Lindsey and J Davies
Prostate Cancer Prostatic Dis 8: 31-35; advance online publication, December 7, 2004; doi:10.1038/sj.pcan.4500774
Papers
MUC1 expression in human prostate cancer cell lines and primary tumors
J C O'Connor, J Julian, S D Lim and D D Carson
Prostate Cancer Prostatic Dis 8: 36-44; advance online publication, October 12, 2004; doi:10.1038/sj.pcan.4500762
Home and office uroflowmetry for evaluation of LUTS from benign prostatic enlargement
D Porru, R M Scarpa, D Prezioso, A Bertaccini and C A Rizzi for HOUSE Study Group
Prostate Cancer Prostatic Dis 8: 45-49; advance online publication, January 18, 2005; doi:10.1038/sj.pcan.4500763
TGFBR1*6A is not associated with prostate cancer in men of European ancestry
B K Suarez, P Pal, C H Jin, R Kaushal, G Sun, L Jin, B Pasche, R Deka and W J Catalona
Prostate Cancer Prostatic Dis 8: 50-53; advance online publication, October 26, 2004; doi:10.1038/sj.pcan.4500765
Expression of biomarkers modulating prostate cancer progression: implications in the treatment of the disease
G Di Lorenzo, S De Placido, R Autorino, M De Laurentiis, C Mignogna, M D'Armiento, G Tortora, G De Rosa, M D'Armiento, M De Sio, A R Bianco and F P D'Armiento
Prostate Cancer Prostatic Dis 8: 54-59; advance online publication, January 18, 2005; doi:10.1038/sj.pcan.4500768
Risk of prostate cancer and family history of cancer: a population-based study in China
Y Bai, Y-T Gao, J Deng, I A Sesterhenn, J F Fraumeni Jr and A W Hsing
Prostate Cancer Prostatic Dis 8: 60-65; advance online publication, January 11, 2005; doi:10.1038/sj.pcan.4500775
Does needle size matter? Patient experience of luteinising hormone-releasing hormone analogue injection
B S I Montgomery, J P Borwell and D M Higgins
Prostate Cancer Prostatic Dis 8: 66-68; advance online publication, February 8, 2005; doi:10.1038/sj.pcan.4500778
Heterocyclic amines and genotype of N-acetyltransferases as risk factors for prostate cancer
P M Rovito Jr, P D Morse, K Spinek, N Newman, R F Jones, C Y Wang and G P Haas
Prostate Cancer Prostatic Dis 8: 69-74; advance online publication, February 1, 2005; doi:10.1038/sj.pcan.4500780
Prevention and management of bicalutamide-induced gynecomastia and breast pain: randomized endocrinologic and clinical studies with tamoxifen and anastrozole
D Saltzstein, P Sieber, T Morris and J Gallo
Prostate Cancer Prostatic Dis 8: 75-83; advance online publication, February 1, 2005; doi:10.1038/sj.pcan.4500782
Putative role of serum insulin-like growth factor–1 (IGF-1) and IGF binding protein-3 (IGFBP-3) levels in the development of prostate cancer in Arab men
E O Kehinde, A O Akanji, O A Mojiminiyi, A A Bashir, A S Daar and R Varghese
Prostate Cancer Prostatic Dis 8: 84-90; doi:10.1038/sj.pcan.4500783
Bicalutamide vs cyproterone acetate in preventing flare with LHRH analogue therapy for prostate cancer—a pilot study
M Sugiono, M H Winkler, A A Okeke, M Benney and D A Gillatt
Prostate Cancer Prostatic Dis 8: 91-94; advance online publication, February 15, 2005; doi:10.1038/sj.pcan.4500784
Association between hormonal genetic polymorphisms and early-onset prostate cancer
M S Forrest, S M Edwards, R Houlston, Z Kote-Jarai, T Key, N Allen, M A Knowles, F Turner, A Ardern-Jones, A Murkin, S Williams, R Oram, CR-UK/BPG UK prostate cancer study collaboratorsD T Bishop and R A Eeles
Prostate Cancer Prostatic Dis 8: 95-102; advance online publication, February 15, 2005; doi:10.1038/sj.pcan.4500785
